Jia-Hua Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jia-Hua Feng has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Guihe Yang
Department of Spine Surgery, Beijing Jishuitan Hospital, National Centre for Orthopaedics, Capital Medical University, Beijing, China
2 shared publications - Ling Wang
JST sarcopenia Research Centre, National Centre for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Beijing, China
2 shared publications Wei Gao
School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China
2 shared publications- Yajun Liu
School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China
2 shared publications Yun-Feng Luo
School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China
2 shared publicationsAnyi Guo
JST Sarcopenia Research Centre, National Center for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, 100035, China
1 shared publication
Latest Publications
- Open Access
- 6 November 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (45) , e51443
Trends in screening tools for sarcopenia: A bibliometric analysis
Background: Sarcopenia, characterized by the progressive loss of skeletal muscle mass, strength, and function, poses a significant health challenge in aging populations. Early identification through effective screening tools is critical to mitigate risks such as falls, fractures, and frailty. This study aimed to analyze global research trends in sarcopenia screening tools using bibliometric methods to identify key contributors and emerging hotspots, thereby guiding future research directions. Methods: Data were retrieved from the Web of Science Core Collection (WoSCC) for the period from January 2013 to March 2025. A total of 180 articles were analyzed using bibliometric tools such as the R package bibliometrix, VOSviewer, and CiteSpace. The analysis focused on publication trends, citation impact, co-authorship networks, and keyword co-occurrence to map research trends and identify influential studies and screening tools. Results: The analysis revealed a steady increase in research output since 2013, with an annual growth rate of 38.16%. China emerged as the leading contributor, accounting for 30% of publications, followed by Japan and Brazil. Among the screening tools investigated, the Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls (SARC-F) questionnaire was the most studied tool, followed by SARC-F combined with calf circumference (SARC-CalF) and calf circumference measurements. Citation analysis highlighted pivotal studies on SARC-F validation, while emerging hotspots included tools like the Mini Sarcopenia Risk Assessment (MSRA) and Ishii test, reflecting a shift toward more practical and accessible screening methods. Conclusion: This bibliometric analysis maps global advancements in sarcopenia screening tools, highlighting China’s prolific research output (30% of publications) and the development of culturally adapted instruments in Japan (Ishii test, Yubi-wakka method). The SARC-F questionnaire dominates research focus, spurring innovations including SARC-CalF and calf circumference metrics. The findings advocate standardized validation frameworks and integration of evidence-based screening into geriatric care policies, emphasizing tool accessibility and clinical utility to combat sarcopenia in aging populations.
- 6 November 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (45) , e51443
Open AccessTrends in screening tools for sarcopenia: A bibliometric analysis
Background: Sarcopenia, characterized by the progressive loss of skeletal muscle mass, strength, and function, poses a significant health challenge in aging populations. Early identification through effective screening tools is critical to mitigate risks such as falls, fractures, and frailty. This study aimed to analyze global research trends in sarcopenia screening tools using bibliometric methods to identify key contributors and emerging hotspots, thereby guiding future research directions. Methods: Data were retrieved from the Web of Science Core Collection (WoSCC) for the period from January 2013 to March 2025. A total of 180 articles were analyzed using bibliometric tools such as the R package bibliometrix, VOSviewer, and CiteSpace. The analysis focused on publication trends, citation impact, co-authorship networks, and keyword co-occurrence to map research trends and identify influential studies and screening tools. Results: The analysis revealed a steady increase in research output since 2013, with an annual growth rate of 38.16%. China emerged as the leading contributor, accounting for 30% of publications, followed by Japan and Brazil. Among the screening tools investigated, the Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls (SARC-F) questionnaire was the most studied tool, followed by SARC-F combined with calf circumference (SARC-CalF) and calf circumference measurements. Citation analysis highlighted pivotal studies on SARC-F validation, while emerging hotspots included tools like the Mini Sarcopenia Risk Assessment (MSRA) and Ishii test, reflecting a shift toward more practical and accessible screening methods. Conclusion: This bibliometric analysis maps global advancements in sarcopenia screening tools, highlighting China’s prolific research output (30% of publications) and the development of culturally adapted instruments in Japan (Ishii test, Yubi-wakka method). The SARC-F questionnaire dominates research focus, spurring innovations including SARC-CalF and calf circumference metrics. The findings advocate standardized validation frameworks and integration of evidence-based screening into geriatric care policies, emphasizing tool accessibility and clinical utility to combat sarcopenia in aging populations.
- Open Access
Iron Deficiency Drives Sarcopenia in the Elderly: HIF-1α-Mediated Fibro-Adipogenic Progenitor Differentiation Induces Fat Infiltration and Impairs Muscle Function
Abnormal iron metabolism is closely linked to sarcopenia; however, the specific iron metabolism features of fat-infiltrating sarcopenia remain poorly understood. Proteomic sequencing revealed that in skeletal muscle with severe fat infiltration, the expression of iron utilization-related proteins was significantly downregulated, whereas that of iron uptake and storage proteins was markedly upregulated, thereby presenting an abnormal iron deficiency (ID) phenotype. Nevertheless, the mechanism by which ID drives intramuscular fat infiltration has not been fully elucidated. Using clinical samples, aged murine ID models, and in vitro cell assays, this study is the first to demonstrate that ID stabilizes hypoxia-inducible factor-1α (HIF-1α), promoting aberrant adipogenic differentiation of fibro-adipogenic progenitors (FAPs), disrupting the homeostatic balance between satellite cells (SCs) and FAPs, exacerbating skeletal muscle fat infiltration, and impairing muscle repair capacity. Notably, treatment with the HIF-1α inhibitor PX478 reversed these pathological alterations and improved muscle function. Collectively, our findings identify the ID-HIF-1α-FAPs axis as a key driver of intramuscular fat infiltration, offering a novel therapeutic target for the clinical management of fat-infiltrating sarcopenia.
Open AccessIron Deficiency Drives Sarcopenia in the Elderly: HIF-1α-Mediated Fibro-Adipogenic Progenitor Differentiation Induces Fat Infiltration and Impairs Muscle Function
Abnormal iron metabolism is closely linked to sarcopenia; however, the specific iron metabolism features of fat-infiltrating sarcopenia remain poorly understood. Proteomic sequencing revealed that in skeletal muscle with severe fat infiltration, the expression of iron utilization-related proteins was significantly downregulated, whereas that of iron uptake and storage proteins was markedly upregulated, thereby presenting an abnormal iron deficiency (ID) phenotype. Nevertheless, the mechanism by which ID drives intramuscular fat infiltration has not been fully elucidated. Using clinical samples, aged murine ID models, and in vitro cell assays, this study is the first to demonstrate that ID stabilizes hypoxia-inducible factor-1α (HIF-1α), promoting aberrant adipogenic differentiation of fibro-adipogenic progenitors (FAPs), disrupting the homeostatic balance between satellite cells (SCs) and FAPs, exacerbating skeletal muscle fat infiltration, and impairing muscle repair capacity. Notably, treatment with the HIF-1α inhibitor PX478 reversed these pathological alterations and improved muscle function. Collectively, our findings identify the ID-HIF-1α-FAPs axis as a key driver of intramuscular fat infiltration, offering a novel therapeutic target for the clinical management of fat-infiltrating sarcopenia.
- Top Cited PapersOpen Access
- 18 September 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 167, 115511
The composition, pharmacological effects, related mechanisms and drug delivery of alkaloids from Corydalis yanhusuo
- 18 September 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 167, 115511
Top Cited PapersOpen AccessThe composition, pharmacological effects, related mechanisms and drug delivery of alkaloids from Corydalis yanhusuo
- 1 November 2021
- Vol. 46 (22) , 5727-5735
[Research progress in synthetic biology of active compounds in Chinese medicinal plants].
Mecicinal plants boast abundant natural compounds with significant pharmacological activity, and such compounds, featuring diversified and complex structures, can be used for research and development of drugs. At present, these natural compounds are directly extracted from herbs which, however, suffer from damaged wild resources and shortage of planting resources attributing to the increasing demand. Moreover, the low content in medicinal plants and complex structures are another challenge to the research and development of drugs. Heterologous synthesis with synthetic biology methods is a solution that has attracted wide attention. Synthetic bio-logy for the production of natural active compounds in Chinese medicinal plants involves the exploration of key enzymes in compound bio-synthetic pathways from plants, analysis of enzyme functions and mechanisms, and reconstruction and optimization of biosynthetic pathways in microorganisms for efficient synthesis of compounds. This study briefed the development process of synthetic biology and the biosynthetic pathways of terpenoids, alkaloids, and flavonoids, and summarized the related strategies of synthetic biology such as the reconstruction and optimization of metabolic pathways, regulation of fermentation process, and strain improvement, and the latest applications of heterogeneous synthetic biology in the production of natural compounds from Chinese medicinals. This study is expected to serve as a reference for the efficient production of terpenoids, alkaloids, flavonoids, and other active compounds from Chinese medicinal plants with strategies of synthetic biology.
- 1 November 2021
- Vol. 46 (22) , 5727-5735
[Research progress in synthetic biology of active compounds in Chinese medicinal plants].
Mecicinal plants boast abundant natural compounds with significant pharmacological activity, and such compounds, featuring diversified and complex structures, can be used for research and development of drugs. At present, these natural compounds are directly extracted from herbs which, however, suffer from damaged wild resources and shortage of planting resources attributing to the increasing demand. Moreover, the low content in medicinal plants and complex structures are another challenge to the research and development of drugs. Heterologous synthesis with synthetic biology methods is a solution that has attracted wide attention. Synthetic bio-logy for the production of natural active compounds in Chinese medicinal plants involves the exploration of key enzymes in compound bio-synthetic pathways from plants, analysis of enzyme functions and mechanisms, and reconstruction and optimization of biosynthetic pathways in microorganisms for efficient synthesis of compounds. This study briefed the development process of synthetic biology and the biosynthetic pathways of terpenoids, alkaloids, and flavonoids, and summarized the related strategies of synthetic biology such as the reconstruction and optimization of metabolic pathways, regulation of fermentation process, and strain improvement, and the latest applications of heterogeneous synthetic biology in the production of natural compounds from Chinese medicinals. This study is expected to serve as a reference for the efficient production of terpenoids, alkaloids, flavonoids, and other active compounds from Chinese medicinal plants with strategies of synthetic biology.